BioHealth News Archive
Frederick biotech Veralox Therapeutics raises $5.4M to support drug development, trials – Baltimore Business Journal
Veralox specializes in developing drugs to address unmet medical needs. It is currently working on therapies to target type 1 diabetes and a medication-induced…
Read More
Here are the six winners of Johnson & Johnson’s innovation challenge – Ventureburn
Healthcare giant Johnson & Johnson today announced the six winners of the Champions of Science Africa Innovation Challenge 2.0 at the 28th World Economic…
Read More
Microsoft (MSFT) Teams Up With AstraZeneca on AI Incubator – Bloomberg
Microsoft Corp. is teaming up with U.K. drugmaker AstraZeneca Plc on creating a health-tech incubator in Paris aimed at bringing new solutions to the…
Read More
Built for Bio: Integrated BioTherapeutics on Vimeo
M. Javad Aman, PhD, President and CEO of Integrated BioTherapeutics, explains how his Montgomery County company is focused on discovery research for the development…
Read More
SBIR Road Tour Coming to UMD- Last Chance to Register!
College Park, Maryland, will serve as a SBIR Road Tour stop for the state of Maryland, and will provide attendees with an opportunity to…
Read More
America’s Most Innovative Leaders: 24 healthcare leaders on the list
Forbes released its annual list of the country's most innovative leaders, comprising 100 founders and CEOs known for encouraging creative and highly successful innovation…
Read More
Johns Hopkins University announces new center for psychedelic research – ABC News
Johns Hopkins University is launching a new center for psychedelic research that will use psychedelic drugs to study the mind and therapies for diseases…
Read More
Machfu Awarded $1M Phase II Extension SBIR Grant from the Department of Energy | Business Wire
Machfu, an industrial Internet of Things technology company, announced today that it has been awarded the Small Business Innovation Research (SBIR) Phase II extension…
Read More
Versant backs new, medtech-focused Vensana Capital fund, launching with $225M | FierceBiotech
Vensana Capital—an independent, medtech-focused venture capital investment firm supported by Versant Ventures—has launched with a $225 million fund and ambitions to support new breakthroughs…
Read More
Children’s National and NCC-PDI Announce $150K NICU Medical Device Competition Finalists and Symposium Keynote Speakers | BioSpace
Organizers of the $150K "Make Your Medical Device Pitch for Kids!" competition today announced the 12 finalists who are advancing to the live pitch…
Read More
Downstream Processing of Complex Molecules, Pure and Simple
Making a therapeutic that contains biological components is just the start of creating a medicine. Then, biopharmaceutical companies must capture that drug and ensure…
Read More
Bristol-Myers teams with BioMotiv to build and buy biotechs | FierceBiotech
Bristol-Myers Squibb has allied with biotech accelerator BioMotiv. The deal sets Bristol-Myers up to found and fund biotechs with BioMotiv before going on to…
Read More
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
2019 CEO Outlook (life sciences cut) – KPMG United States
Low interest rates and high stock valuations are fueling U.S. life sciences CEOs’ growing appetite for mergers and acquisitions, KPMG’s CEO Outlook found. {iframe}https://home.kpmg/us/en/home/media/press-releases/2019/09/us-life-sciences-ceos-see-financial-drivers-as-catalyst-for-m-and-a-kpmg-poll.html{/iframe}
Read More
Key details in Viela Bio’s $150 million IPO – Washington Business Journal
It’s a pivotal moment for the MedImmune spinout, which has put the fate of its first prospective product in regulators' hands. {iframe}https://www.bizjournals.com/washington/news/2019/09/03/5-things-to-know-ahead-of-viela-bio-s-planned-150m.html{/iframe}
Read More